What are the diagnostic criteria for Acute Respiratory Distress Syndrome (ARDS) in a patient presenting with sepsis (Systemic Inflammatory Response Syndrome)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Acute Respiratory Distress Syndrome (ARDS) is defined by the Berlin criteria as acute onset respiratory failure within 7 days of a known clinical insult, bilateral opacities on chest imaging not fully explained by effusions or collapse, respiratory failure not fully explained by cardiac failure or fluid overload, and impaired oxygenation with a PaO2/FiO2 ratio ≤ 300 mmHg with PEEP or CPAP ≥ 5 cmH2O, as stated in the study by 1. ARDS severity is classified as mild (PaO2/FiO2 200-300), moderate (PaO2/FiO2 100-200), or severe (PaO2/FiO2 < 100). When evaluating a patient with sepsis for ARDS, first determine if they have developed acute hypoxemic respiratory failure within a week of sepsis onset. Check chest imaging for bilateral infiltrates and ensure the respiratory failure isn't primarily due to heart failure. Measure the PaO2/FiO2 ratio while the patient is on at least 5 cmH2O of PEEP. In sepsis patients, ARDS commonly develops due to direct lung injury from pneumonia or indirect injury from the systemic inflammatory response. Management includes treating the underlying sepsis with appropriate antibiotics and source control, lung-protective ventilation (tidal volumes 4-8 mL/kg predicted body weight, plateau pressures < 30 cmH2O) as recommended by 1 and 1, conservative fluid management once hemodynamically stable, prone positioning for severe ARDS, and consideration of neuromuscular blockade in the first 48 hours for severe cases, as suggested by 1 and 1. Early recognition of ARDS in septic patients is crucial as it significantly impacts ventilation strategies and overall management. Key considerations in managing sepsis-induced ARDS include the use of higher PEEP over lower PEEP in moderate to severe cases, recruitment maneuvers in severe cases, and the avoidance of high-frequency oscillatory ventilation, as outlined in the guidelines by 1 and 1. Additionally, a conservative fluid strategy is recommended for patients with established sepsis-induced ARDS who do not have evidence of tissue hypoperfusion, as stated in 1 and 1. The management of ARDS in sepsis patients should prioritize lung-protective ventilation, appropriate use of PEEP, and conservative fluid management, as supported by the highest quality evidence from 1, 1, 1, and 1.

Some key points to consider in the management of ARDS in sepsis patients include:

  • Using a target tidal volume of 6 mL/kg predicted body weight compared with 12 mL/kg, as recommended by 1 and 1
  • Using an upper limit goal for plateau pressures of 30 cm H2O, as recommended by 1 and 1
  • Using higher PEEP over lower PEEP in moderate to severe ARDS, as suggested by 1 and 1
  • Using recruitment maneuvers in severe ARDS, as suggested by 1 and 1
  • Using prone positioning in severe ARDS, as recommended by 1 and 1
  • Considering neuromuscular blockade in the first 48 hours for severe ARDS, as suggested by 1 and 1
  • Implementing a conservative fluid strategy, as recommended by 1 and 1

From the Research

Definition of ARDS

The criteria for Acute Respiratory Distress Syndrome (ARDS) include:

  • Onset within one week of a known clinical insult or new or worsening respiratory symptoms
  • Bilateral opacities on chest imaging not fully explained by effusions, lobar/lung collapse, or nodules
  • Respiratory failure not fully explained by cardiac failure or fluid overload
  • Impaired oxygenation, as indicated by a ratio of partial pressure of arterial oxygen to fraction of inspired oxygen (PaO2/FiO2) less than 300 mmHg, with a positive end-expiratory pressure (PEEP) or continuous positive airway pressure (CPAP) ≥ 5 cmH2O 2

Application to a Patient with Sepsis

A patient presenting with sepsis may be at risk for developing ARDS, as sepsis is a major cause of ARDS, accounting for approximately 70% of cases 2. The patient's condition should be closely monitored for signs of respiratory distress, including:

  • Hypoxemia, as indicated by a low PaO2/FiO2 ratio
  • Bilateral infiltrates on chest imaging
  • Increased respiratory rate or difficulty breathing If the patient meets the criteria for ARDS, mechanical ventilation may be necessary to support oxygenation and prevent further lung injury 2. The ventilatory strategy should aim to achieve adequate oxygenation while minimizing the risk of ventilator-induced lung injury, which is a particular concern in patients with sepsis-related ARDS 2.

Management of Sepsis-Related ARDS

The management of sepsis-related ARDS involves a multifaceted approach, including:

  • Fluid resuscitation to maintain adequate blood pressure and perfusion
  • Vasopressor therapy, such as norepinephrine, to support blood pressure and organ perfusion 3, 4, 5, 6
  • Broad-spectrum antibiotics to treat the underlying infection
  • Mechanical ventilation with a lung-protective strategy to support oxygenation and prevent further lung injury 2
  • Consideration of adjunctive therapies, such as corticosteroids or neuromuscular blockers, in selected cases 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mechanical Ventilation in Sepsis: A Reappraisal.

Shock (Augusta, Ga.), 2017

Research

Vasopressors During Sepsis: Selection and Targets.

Clinics in chest medicine, 2016

Research

Vasopressors in septic shock: which, when, and how much?

Annals of translational medicine, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.